Breaking News Instant updates and real-time market news.

SNY

Sanofi

$49.79

0.24 (0.48%)

, REGN

Regeneron

$435.43

0.46 (0.11%)

05:36
09/28/17
09/28
05:36
09/28/17
05:36

Sanofi, Regeneron announce approval of Dupixent in EU

Sanofi (SNY) and Regeneron (REGN) announced that the European Commission has granted marketing authorization for Dupixent, for use in adults with moderate-to-severe atopic dermatitis, or AD, who are candidates for systemic therapy. Dupixent is approved in the U.S. for the treatment of adults with moderate-to-severe atopic dermatitis that is not well controlled with prescription therapies used on the skin, or who cannot use topical therapies. Dupixent can be used with or without topical corticosteroids. It is not known if Dupixent is safe and effective in children.

SNY

Sanofi

$49.79

0.24 (0.48%)

REGN

Regeneron

$435.43

0.46 (0.11%)

  • 18

    Oct

SNY Sanofi
$49.79

0.24 (0.48%)

07/31/17
ADAM
07/31/17
NO CHANGE
Target $522
ADAM
Buy
Dupixent authorization approval rate outweighs Q2 miss, says Canaccord
Regeneron (REGN) partner Sanofi (SNY) reported a "very high" 73%-83% prior authorization approval rate for Dupixent in Q2, which Canaccord analyst John Newman said outweighs the fact that sales for the drug at $30.6M were slightly below the $33M consensus forecast. The analyst, who sees rapid payor acceptance of Dupixent as "much more crucial" than the initial quarterly revenue, keeps a Buy rating and $522 price target on Regeneron shares.
08/30/17
HSBC
08/30/17
UPGRADE
Target $81
HSBC
Hold
Sanofi upgraded to Hold from Reduce at HSBC
HSBC analyst Steve McGarry upgraded Sanofi to Hold and increased its price target to $81 from $79 citing valuation and said he sees few catalysts to own the shares either.
08/30/17
08/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sanofi (SNY) upgraded to Hold from Reduce at HSBC, with analyst Steve McGarry citing valuation. 2. M.D.C. Holdings (MDC) upgraded to Market Perform from Underperform at Wells Fargo with analyst Stephen East saying he sees "little reason the equity would move meaningfully lower" from current levels. 3. Ciena (CIEN) upgraded to Buy from Neutral at Citi with analyst Stanley Kovler saying the risk/reward is positive into third quarter results. 4. Six Flags (SIX) upgraded to Buy from Neutral at Hilliard Lyons with analyst Jeff Thomison citing improved valuation based on its 13% year-to-date pullback. 5. Prospect Capital (PSEC) upgraded to Market Perform from Underperform at Raymond James with analyst Robert Dodd saying he expects near-term earnings will cover the lower dividend run-rate but notes downside risk remains. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
FBCO
09/11/17
NO CHANGE
Target $485
FBCO
Outperform
Regeneron, Sanofi asthma trial 'statistically significant,' says Credit Suisse
Credit Suisse analyst Alethia Young notes that Regeneron (REGN)/Sanofi (SNY) released top-line asthma results, and the overall trial was "statistically significant." Specifically, the trial hit in the overall population, but it is unclear if the trial was statistically significant in the low eosinophil level patients alone, she notes. The analyst reiterates an Outperform rating and $485 price target on Regeneron's shares.
REGN Regeneron
$435.43

0.46 (0.11%)

09/11/17
PIPR
09/11/17
NO CHANGE
Target $557
PIPR
Overweight
Regeneron pullback today a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff recommends using today's weakness in shares of Regeneron Pharmaceuticals as a buying opportunity. The analyst calls the Phase III Quest data in severe asthma patients positive and projects peak U.S. asthma sales of $2.2B by 2025. He reiterates an Overweight rating on Regeneron with a $557 price target. The stock in early trading is down 6% to $443.39.
09/14/17
RBCM
09/14/17
INITIATION
Target $475
RBCM
Sector Perform
Regeneron initiated with a Sector Perform at RBC Capital
RBC Capital analyst Kennen MacKay initiated Regeneron with a Sector Perform and a $475 price target.
09/21/17
UBSW
09/21/17
NO CHANGE
Target $500
UBSW
Buy
Regeneron price target lowered to $500 from $535 at UBS
UBS analyst Carter Gould lowered his price target on Regeneron (REGN) to $500 from $535 citing increased Dupixent competition after Amgen (AMGN) and AstraZeneca (AZN) reported data on their own asthma drug earlier this month and AbbVie (ABBV) reported results in an atopic dermatitis study. While he noted that definitive 12-month phase 3 data from these competitors is likely more than 20 months away, he also lowered his Dupixent peak sales estimate to $4.8B from $6.5B. He keeps a Buy rating on Regeneron shares, as he believes pipeline products including nesvacumab and REGN2810 offer a path to longer-term upside.

TODAY'S FREE FLY STORIES

NBL

Noble Energy

$29.58

0.45 (1.54%)

15:20
02/22/18
02/22
15:20
02/22/18
15:20
Options
Notable call buying in Noble Energy as shares advance »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

HLF

Herbalife

$83.29

0.35 (0.42%)

15:19
02/22/18
02/22
15:19
02/22/18
15:19
Options
Herbalife options imply 11.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BLK

BlackRock

$540.70

-2.86 (-0.53%)

, RGR

Sturm, Ruger

$48.75

1.45 (3.07%)

15:17
02/22/18
02/22
15:17
02/22/18
15:17
Periodicals
BlackRock to speak with gun makers, distributors after FL shooting, Reuters says »

BlackRock (BLK) said it…

BLK

BlackRock

$540.70

-2.86 (-0.53%)

RGR

Sturm, Ruger

$48.75

1.45 (3.07%)

AOBC

American Outdoor Brands

$10.06

-0.12 (-1.18%)

WMT

Walmart

$92.78

1.26 (1.38%)

DKS

Dick's Sporting

$32.94

0.1 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 06

    Mar

  • 07

    Mar

  • 07

    Mar

  • 18

    Mar

  • 23

    Apr

$NSD

NASDAQ Market Internals

15:17
02/22/18
02/22
15:17
02/22/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTLS

Chart Industries

$49.71

-0.26 (-0.52%)

15:16
02/22/18
02/22
15:16
02/22/18
15:16
Upgrade
Chart Industries rating change  »

Chart Industries upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 14

    Mar

$NYE

NYSE Market Internals

15:16
02/22/18
02/22
15:16
02/22/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
02/22/18
02/22
15:15
02/22/18
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

15:15
02/22/18
02/22
15:15
02/22/18
15:15
General news
Breaking General news story  »

Dallas Federal Reserve…

BLK

BlackRock

$542.19

-1.37 (-0.25%)

15:10
02/22/18
02/22
15:10
02/22/18
15:10
Periodicals
BlackRock plans to engage with gun makers, sellers, Bloomberg says »

BlackRock, one of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 01

    Mar

  • 06

    Mar

  • 07

    Mar

  • 23

    Apr

FSLR

First Solar

$66.70

0.12 (0.18%)

15:04
02/22/18
02/22
15:04
02/22/18
15:04
Options
First Solar options imply 12.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

XLF

Financial Select Sector

$28.85

-0.079 (-0.27%)

, XLV

Health Care Select Sector SPDR

$84.25

0.13 (0.15%)

15:03
02/22/18
02/22
15:03
02/22/18
15:03
Technical Analysis
Technical Take: S&P 500 falls to session lows heading into last hour of trading »

The S&P 500 (SPX) was…

XLF

Financial Select Sector

$28.85

-0.079 (-0.27%)

XLV

Health Care Select Sector SPDR

$84.25

0.13 (0.15%)

XRT

S&P Retail Index SPDR

$45.41

0.07 (0.15%)

SPY

SPDR S&P 500 ETF Trust

$271.15

1.1 (0.41%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASFI

Asta Funding

$10.60

0.7 (7.07%)

15:02
02/22/18
02/22
15:02
02/22/18
15:02
Hot Stocks
Asta Funding announces receipt of Nasdaq non-compliance letter »

Asta Funding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$166.36

1.44 (0.87%)

14:59
02/22/18
02/22
14:59
02/22/18
14:59
Periodicals
Massachusetts officials say Wynn investigation a priority, Bloomberg says »

Officials from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNN

National Retail Properties

$37.99

0.93 (2.51%)

14:58
02/22/18
02/22
14:58
02/22/18
14:58
Syndicate
Breaking Syndicate news story on National Retail Properties »

National Retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRI

Nutrisystem

$41.10

-0.2 (-0.48%)

14:50
02/22/18
02/22
14:50
02/22/18
14:50
Options
Healthy put spread in NutriSystems ahead of earnings »

Healthy put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OLED

Universal Display

$155.60

-5.5 (-3.41%)

14:49
02/22/18
02/22
14:49
02/22/18
14:49
Options
Universal Display options imply 12.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

AMD

AMD

$11.72

-0.3 (-2.50%)

14:40
02/22/18
02/22
14:40
02/22/18
14:40
Options
AMD put volume tops 100K contracts »

AMD put volume tops 100K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MIC

Macquarie Infrastructure

$37.98

-25.64 (-40.30%)

14:30
02/22/18
02/22
14:30
02/22/18
14:30
Hot Stocks
Macquarie Infrastructure plunges after cutting dividend »

Shares of Macquarie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

14:30
02/22/18
02/22
14:30
02/22/18
14:30
General news
FX Action: USD-JPY »

FX Action: USD-JPY was…

PEG

PSEG

$49.26

0.73 (1.50%)

, COG

Cabot Oil & Gas

$24.07

0.82 (3.53%)

14:28
02/22/18
02/22
14:28
02/22/18
14:28
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PEG

PSEG

$49.26

0.73 (1.50%)

COG

Cabot Oil & Gas

$24.07

0.82 (3.53%)

HUN

Huntsman

$33.50

-0.09 (-0.27%)

CNK

Cinemark

$39.95

0.33 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 05

    Mar

  • 23

    May

INTU

Intuit

$173.32

-0.25 (-0.14%)

, HPQ

HP Inc.

$21.41

0.24 (1.13%)

14:27
02/22/18
02/22
14:27
02/22/18
14:27
Earnings
Notable companies reporting after market close »

Notable companies…

INTU

Intuit

$173.32

-0.25 (-0.14%)

HPQ

HP Inc.

$21.41

0.24 (1.13%)

HPE

HP Enterprise

$16.40

0.145 (0.89%)

BMRN

BioMarin

$84.21

0.36 (0.43%)

GDDY

GoDaddy

$55.13

-0.57 (-1.02%)

OLED

Universal Display

$155.60

-5.5 (-3.41%)

HLF

Herbalife

$83.42

0.48 (0.58%)

FSLR

First Solar

$66.70

0.12 (0.18%)

EXAS

Exact Sciences

$46.64

-1.37 (-2.85%)

PLNT

Planet Fitness

$33.17

-0.51 (-1.51%)

TTD

Trade Desk

$49.81

-0.39 (-0.78%)

WING

Wingstop

$45.73

1.7 (3.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 15

    Mar

  • 22

    Mar

  • 28

    Mar

  • 24

    Apr

  • 25

    May

  • 30

    May

  • 12

    Sep

14:25
02/22/18
02/22
14:25
02/22/18
14:25
General news
NASDAQ comp briefly rolled over into the red »

NASDAQ comp briefly…

TGNA

Tegna

$13.73

-0.26 (-1.86%)

14:17
02/22/18
02/22
14:17
02/22/18
14:17
Hot Stocks
TEGNA names Howard Elias non-executive chairman of the board »

TEGNA announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

$NSD

NASDAQ Market Internals

14:17
02/22/18
02/22
14:17
02/22/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
02/22/18
02/22
14:16
02/22/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.